$337M | ||
$259M | ||
$79M | ||
$75M | ||
$60M | ||
$56M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the …
Over the last 12 months, insiders at Bluejay Diagnostics, Inc. have bought $0 and sold $0 worth of Bluejay Diagnostics, Inc. stock.
On average, over the past 5 years, insiders at Bluejay Diagnostics, Inc. have bought $61,573 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 500 shares for transaction amount of $1,635 was made by Dey Indranil (President and CEO) on 2023‑12‑13.
2023-12-13 | Dey Indranil | President and CEO | 500 0.044% | $3.27 | $1,635 | -85.64% | ||
2023-12-13 | Dey Svetlana | director | 500 0.0413% | $3.07 | $1,535 | -85.64% | ||
2023-03-28 | Dey Indranil | President and CEO | 2,000 0.0105% | $0.44 | $880 | -49.65% | ||
2023-03-27 | Dey Indranil | President and CEO | 8,000 0.0393% | $0.44 | $3,520 | -53.01% | ||
2023-03-24 | Dey Svetlana | director | 10,000 0.0502% | $0.44 | $4,400 | -51.67% | ||
2022-08-26 | Fisher Kenneth R | Chief Financial Officer | 20,000 0.0992% | $1.03 | $20,600 | -57.23% | ||
2022-04-25 | Fisher Kenneth R | Chief Financial Officer | 20,000 0.0943% | $0.99 | $19,800 | -21.74% | ||
2022-03-17 | Wurth Douglas Clark | 40,000 0.1983% | $1.18 | $47,120 | -24.35% | |||
2022-03-17 | Kinder Gordon Winston | Chief Financial Officer | 2,500 0.0122% | $1.16 | $2,898 | -24.35% | ||
2022-03-17 | Dey Svetlana | 10,000 0.0498% | $1.18 | $11,830 | -24.35% | |||
2022-03-16 | Wurth Douglas Clark | 60,000 0.2823% | $1.09 | $65,400 | -20.91% | |||
2022-03-14 | Kinder Gordon Winston | Chief Financial Officer | 5,000 0.0274% | $1.02 | $5,100 | +1.69% |
Increased Positions | 5 | +27.78% | 2,456 | +12.08% |
Decreased Positions | 9 | -50% | 18,952 | -93.24% |
New Positions | 2 | New | 1,326 | New |
Sold Out Positions | 9 | Sold Out | 18,952 | Sold Out |
Total Postitions | 14 | -22.22% | 3,829 | -81.16% |
Ubs Group Ag | $7.00 | 0.2% | 1,945 | +716 | +58.26% | 2024-12-31 |
Cvi Holdings, Llc | $5.00 | 0.13% | 1,323 | +1,323 | New | 2024-06-30 |
Tower Research Capital Llc (Trc) | $2.00 | 0.06% | 554 | +411 | +287.41% | 2024-12-31 |
Bank Of America Corp /De/ | $0 | 0% | 4 | +3 | +300% | 2024-12-31 |
Osaic Holdings, Inc. | $0 | 0% | 3 | +3 | New | 2024-12-31 |
Hrt Financial Lp | $0 | 0% | 0 | -793 | Sold Out | 2024-12-31 |
Jump Financial, Llc | $0 | 0% | 0 | -208 | Sold Out | 2024-12-31 |
Citadel Advisors Llc | $0 | 0% | 0 | -1,044 | Sold Out | 2024-12-31 |
Anson Funds Management Lp | $0 | 0% | 0 | -6,386 | Sold Out | 2024-12-31 |
Geode Capital Management, Llc | $0 | 0% | 0 | -404 | Sold Out | 2024-12-31 |